None listed
Conditions
Brief summary
The purpose of the study is to determine whether the act of measuring and providing feedback on adherence will result in a change in adherence with preventive medication and as a secondary outcome disease control. Subjects who are aware that their use of medication is being monitored may change their behaviour. Providing feedback may provide them and thier physician with additional information which may improve the accuracy and quality of clinical decisions that are made.
Interventions
Adherence of preventive medication will be monitored using an electronic monitoring device (Smirtinhaler, Nexus 6) in a cohort of 100 children aged 6-15 years with asthma. Data from the device may be downloaded and displayed graphically to the participants. The intervention group will receive monthly feedback regarding their us e of preventive medication along with standard asthma care. The control group will have their adherence monitored but this will remain confidential and will not be fedbac
Adherence of preventive medication will be monitored using an electronic monitoring device (Smirtinhaler, Nexus 6) in a cohort of 100 children aged 6-15 years with asthma. Data from the device may be downloaded and displayed graphically to the participants. The intervention group will receive monthly feedback regarding their us e of preventive medication along with standard asthma care. The control group will have their adherence monitored but this will remain confidential and will not be fedback to the participants. The trial is likely to take 2 years to complete. Each child will be in the study for 4 months.
Sponsors
Redland Hospital
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
6 Years to 15 Years
Healthy volunteers
No
Inclusion criteria
Aged 6 - 15 years, frequent episodic or chronic persistent asthma, taking daily preventive inhaled corticosteroid medication.
Exclusion criteria
Other underlying lung disorder, not taking inhaled corticosteroid medication.
Outcome results
None listed